News

Evaluating Respiratory Enzyme Activity in Kidney Biopsies May Help Diagnose Mitochondrial Disease, Study Finds

Determining the respiratory chain enzyme activity in kidney tissue samples could provide useful information for diagnosing mitochondrial dysfunction in children with renal impairment, according to a report in the Journal of Clinical Medicine. Diseases stemming from mitochondrial dysfunction can be difficult to diagnose because of symptoms similar to other…

Stealth’s Elamipretide Granted FDA Orphan Drug Status for Primary Mitochondrial Myopathy

Stealth BioTherapeutics‘ investigational medicine elamipretide, formerly known as Bendavia, has been granted orphan drug status by the U.S. Food and Drug Administration’s (FDA) for the treatment of primary mitochondrial myopathy (PMM). Stealth specializes in the development of drug candidates for mitochondrial disease treatment. The FDA’s Office of Orphan…

Mitobridge Adds NAD+ Modulation as Therapeutic Approach for Mitochondrial Function

The therapeutics platform developed by Mitobridge, a biopharmaceutical company developing medicines to improve mitochondria function, will now include modulators of the Nicotinamide Adenine Dinucleotide (NAD+) pathway, the company announced. NAD+ is an essential coenzyme to our cells’ metabolic reactions, cell signaling and energy production by mitochondria. A coenzyme is a small…